Reaction
Post Herpetic Neuralgia reporting signals
As of the last recalculation, Post Herpetic Neuralgia appears in 1,420 FAERS reports alongside 28 co-occurring drug terms. The strongest observed disproportionality signal is BARICITINIB (PRR 29.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Baricitinib | 19 | 29.3 | 29.3 |
| Alemtuzumab | 25 | 19.3 | 19.3 |
| Psyllium Husk | 10 | 14.9 | 14.9 |
| Valacyclovir Hydrochloride | 66 | 14.3 | 14.4 |
| Dalteparin Sodium | 10 | 13.9 | 14.0 |
| Febuxostat Tablets 40 Mg | 9 | 13.0 | 13.1 |
| Febuxostat Tablets 80 Mg | 9 | 13.0 | 13.1 |
| Ado-Trastuzumab Emtansine | 7 | 12.2 | 12.2 |
| Siponimod | 7 | 11.6 | 11.6 |
| Fosaprepitant Dimeglumine | 10 | 10.7 | 10.7 |
| Daspone | 7 | 10.6 | 10.6 |
| Dapsone Gel, 5% | 7 | 10.6 | 10.6 |
| Pregabalin | 172 | 10.4 | 10.4 |
| Ruxolitinib | 48 | 10.1 | 10.1 |
| Valacyclovir | 27 | 9.7 | 9.7 |
| Fingolimod Hcl | 54 | 9.5 | 9.5 |
| Tapentadol Hydrochloride | 20 | 8.9 | 8.9 |
| Aprepitant | 11 | 8.8 | 8.8 |
| Bendamustine Hydrochloride | 7 | 8.6 | 8.6 |
| Acyclovir | 60 | 8.0 | 8.0 |
| Dronedarone | 5 | 7.2 | 7.2 |
| Belimumab | 14 | 6.5 | 6.5 |
| Tofacitinib | 74 | 6.1 | 6.1 |
| Ibrutinib | 33 | 6.1 | 6.1 |
| Ocrelizumab | 21 | 5.0 | 5.0 |
| Diroximel Fumarate | 4 | 4.9 | 4.9 |
| Ixazomib | 9 | 4.6 | 4.6 |
| Sarilumab | 8 | 4.5 | 4.5 |